CVS Caremark Expands Efforts to Address Health Disparities

0

What you should know:

CVS Caremark announced an expansion of its efforts to address health disparities among patients, starting with certain conditions including sickle cell disease, HIV and cardiovascular disease.

– CVS Caremark works with clients to create health equity strategies for PBM members with certain conditions that disproportionately affect patients of color. The company will also use its broad reach and work with community partners to determine the best ways to influence systemic change for those who have struggled with the disease for many years and for newly diagnosed members.

CVS Caremark’s approach to tackling health disparities

CVS Caremark’s approach will focus on the following principles:

– A four-pillar programmatic approach: 1) awareness and educational resources, 2) screening and screening, 3) access to health services, and 4) treatment optimization interventions

– Collaborate with community organizations and patient advocacy groups to provide care where people are

Use company assets, including healthcare services available in CVS HealthHUB® locations and legacy corporate social responsibility programs such as Project Health, as applicable

– Measure and share results continuously for continuous learning

– Collaborate with community organizations and patient advocacy groups to provide care where people are

– Use company assets, including healthcare services available in CVS HealthHUB® locations and legacy corporate social responsibility programs such as Project Health, as applicable

– Measure and share results continuously for continuous learning

Double the sickle cell disease

Among its goals are doubling the number of patients on hydroxyurea for people living with sickle cell disease (SCD), improving adherence in those already taking the drug, and significantly increasing trait testing. SCD is an incredibly painful condition that primarily affects communities of color and, if left untreated, can lead to life-threatening complications. Hydroxyurea, an inexpensive drug, can help patients better manage their condition by reversing sickling of blood cells. In some areas, the number of people with sickle cell disease has doubled because many people who carry the trait that can lead to the development of the disease do not know it. Increasing feature testing by starting with greater awareness and education can help consumers make more informed decisions. CVS Caremark plans to work with national and community organizations to understand the needs of local communities and develop programs to increase awareness and access.

Increased awareness of HIV testing and prevention

The company is also adding to existing initiatives to increase awareness of HIV testing and prevention for CVS Caremark members, particularly among communities of color by sharing educational resources with those at risk and supporting patients. to initiate preventive treatment if necessary. These efforts are in addition to the company’s continued participation in the US Department of Health and Human Services Ready, Set, PrEP initiative to eliminate 90% of new HIV infections by 2030 and help end the AIDS epidemic. While a host of social, economic, and demographic factors impact HIV transmission rates in the United States, people with low incomes, minorities (especially African Americans and Hispanics / Latinos) and LGBTQ + populations are among the most vulnerable to HIV.

Heart disease

For cardiovascular disease, CVS Caremark aims to increase the initiation of drug therapy in people with health disparities and to ensure that those already on treatment receive an optimized dosage to meet their target blood pressure and stay adherent to it. their diet.

Across all areas of illness, the company will work with local community organizations and advocacy groups to ensure that people facing health inequalities have access to the resources and care they need.


Source link

Share.

Leave A Reply